Pfizer Vaccine on Track for Regulatory Review in October – Bloomberg

0
6
Pfizer Vaccine on Track for Regulatory Review in October – Bloomberg

Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from an early-stage study.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here